Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
2017 · Science · 6,510 citations
https://doi.org/10.1126/science.aan6733
K
Katherine M. Bever
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
7.8K
Citations
15
h-index
17
i10-index
Katherine M. Bever is an academic researcher from Bloomberg (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Genetic factors in colorectal cancer. The author has an h-index of 15, co-authored 125 publications.
ORCID: 0000-0001-5230-4661Papers by this author
worksA feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
2021 · Clinical Epigenetics · 28 citations
https://doi.org/10.1186/s13148-021-01014-8
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
2024 · JCI Insight · 9 citations
https://doi.org/10.1172/jci.insight.179292
Immunotherapy in gastroesophageal adenocarcinoma: What is the state of management?
2024 · Surgical Oncology Insight · 0 citations
https://doi.org/10.1016/j.soi.2024.100099
Postsurgical circulating tumor DNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma
2026 · Journal of Gastrointestinal Surgery · 0 citations
https://doi.org/10.1016/j.gassur.2026.102359
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
2026 · Nature Communications · 0 citations
https://doi.org/10.1038/s41467-026-68324-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat